We have a chance to get a joint document of principles tomorrow.

We have a chance to get a joint document of principles tomorrow.

What we found was that age was a significant predictor in Bt corn adoption. We found as producers get older read more

What we found was that age was a significant predictor in Bt corn adoption. We found as producers get older and gain experience they are more likely to adopt Bt corn rootworm, but once they reach about age 48 they become less likely to adopt the technology.

While we continue to see a court monitor as unnecessary and counter productive, we are open to finding ways to read more

While we continue to see a court monitor as unnecessary and counter productive, we are open to finding ways to work together to better address issues of concern to the community.

It is better to be violent, if there is violence in our hearts, than to put on the cloak of read more

It is better to be violent, if there is violence in our hearts, than to put on the cloak of nonviolence to cover impotence.

You have to credit my teammates. Without them I wouldn't have had any assists.

You have to credit my teammates. Without them I wouldn't have had any assists.

It's improved my physical strength, and I'm getting a lot better. There's not as much frustration.

It's improved my physical strength, and I'm getting a lot better. There's not as much frustration.

The latest chip helps us go after the Web and application tier in the data center,

The latest chip helps us go after the Web and application tier in the data center,

So we've been preparing for this and all we're ready to do is do more of what we've been doing.

So we've been preparing for this and all we're ready to do is do more of what we've been doing.

[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, read more

[Many drugs are prescribed outside their official recommendations, she says. Neurontin, for example, was initially approved only for epilepsy. But, after a slow start, it grew to become a $US2.3 billion ($3 billion today) blockbuster for its owner, Pfizer, in 2003.] About 80 per cent of the prescriptions were for unapproved uses - conditions like bipolar disorder, post-traumatic stress disorder, insomnia, restless legs syndrome, hot flashes, migraines and tension headaches, ... In fact, Neurontin has become a sort of all-purpose restorative for chronic discomfort of almost any type - yet there is almost no good published evidence that it works.